Filing an Ozempic Lawsuit: Legal Process and Eligibility

Thousands of patients nationwide have filed claims against Novo Nordisk after experiencing serious health complications from Ozempic and other semaglutide medications, with over 2,809 lawsuits now consolidated in federal multidistrict litigation (MDL 3094) in the Eastern District of Pennsylvania.

These legal actions stem from allegations that the pharmaceutical manufacturer failed to adequately warn patients and healthcare providers about severe gastrointestinal injuries, including gastroparesis (stomach paralysis), and vision loss conditions like non-arteritic anterior ischemic optic neuropathy (NAION).

The litigation addresses both individuals who used these medications for FDA-approved diabetes management and those prescribed Ozempic off-label for weight loss, with plaintiffs seeking compensation for debilitating injuries that have altered their quality of life.

Current Status of the Ozempic MDL

MDL 3094, formally titled “In Re: Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation,” consolidates federal lawsuits filed across the United States into a single court for streamlined pretrial proceedings.

U.S. District Judge Karen S. Marston presides over this litigation in Pennsylvania, managing discovery, expert testimony standards, and procedural timelines that will shape the path forward for thousands of injured patients.

The case count has grown rapidly throughout 2025, with approximately 100-200 new Ozempic lawsuits joining the MDL each month.

As of October 2025, the litigation encompasses 2,809 pending federal lawsuits, representing patients who developed serious complications after using Ozempic, Wegovy, Rybelsus, and similar GLP-1 receptor agonist medications marketed as diabetes treatments and weight management drugs manufactured by Novo Nordisk and Eli Lilly.

Legal experts anticipate this number will continue rising as many patients come forward, with plaintiff attorneys reporting approximately 7,000 additional potential cases currently under investigation.

State Court Proceedings and NAION Vision Loss Claims

Separate state court proceedings have emerged in New Jersey specifically for vision loss claims involving NAION.

Plaintiffs in these state court actions seek to pursue their claims outside the federal MDL structure, arguing that vision loss cases present distinct scientific and medical questions that warrant independent handling.

A petition for multicounty litigation consolidation in New Jersey state courts remains under consideration, while some attorneys have filed motions requesting that NAION cases be transferred to Judge Marston’s MDL for coordinated management.

The litigation timeline shows that fact discovery for certain issues was completed in October 2025, with expert reports from plaintiffs due in December 2025 and defense expert disclosures following shortly after.

Health Complications Driving Legal Claims

Gastroparesis and Digestive System Injuries

Gastroparesis, an Ozempic-linked condition where the stomach’s ability to empty properly becomes impaired or stops entirely, stands as one of the most frequently alleged injuries in the litigation.

This debilitating condition occurs when the medication’s mechanism of slowing digestion and affecting insulin production to create feelings of fullness progresses to chronic dysfunction requiring long-term medical management.

Patients with gastroparesis experience severe nausea, vomiting after eating minimal amounts of food, persistent abdominal pain and bloating, and dangerous nutritional deficiencies that can lead to hospitalization and feeding tube dependency.

Judge Marston issued a ruling in August 2025 requiring that gastroparesis claims be supported by objective medical testing rather than clinical observation alone.

Plaintiffs must present results from properly performed gastric emptying studies (including scintigraphy (nuclear medicine test), breath testing, or wireless motility capsule examination) to demonstrate delayed stomach emptying consistent with gastroparesis diagnosis.

This requirement has shaped case qualification standards and made thorough medical documentation particularly important for patients seeking to join the litigation.

NAION Vision Loss Claims

NAION vision loss cases represent another serious category of injuries alleged in the litigation.

This rare eye condition involves sudden loss of blood flow to the optic nerve, resulting in partial or total blindness that typically cannot be reversed.

Research published in JAMA Ophthalmology found that patients using semaglutide showed four times the risk of developing NAION compared to those on other diabetes drugs.

The European Medicines Agency concluded in June 2025 that NAION constitutes a very rare side effect of semaglutide medications, raising serious concerns that led to updated warnings in Europe.

Additional Reported Complications

Additional complications reported in the litigation include ileus (bowel obstruction), which the FDA added to Ozempic warning labels in September 2023 after recognizing a significantly increased risk, along with severe vomiting requiring hospitalization, gallbladder inflammation and removal, acute pancreatitis, and blood clotting disorders including pulmonary embolism.

The scope of alleged injuries continues to expand as more patients come forward with serious health complications including gastroparesis, vision loss, and deep vein thrombosis they attribute to GLP-1 medications.

Plaintiffs claim that drug companies like Novo Nordisk knew or should have known about these risks through pre-market testing and post-market surveillance data, yet failed to provide adequate warnings that would have allowed patients and physicians to make informed treatment decisions.

Not everyone who experienced side effects and health risks from Ozempic qualifies to file a lawsuit – specific medical and legal criteria must be met to pursue compensation.

These requirements exist because pharmaceutical product liability claims require proof that the medication caused serious injury and that the manufacturer failed to provide adequate warnings about known risks.

Early assessment of eligibility helps protect your legal rights if you suffered injuries and prevents missing filing deadlines that could bar you from seeking compensation.

Primary Eligibility Requirements

Three core requirements must be met to pursue an Ozempic lawsuit, each supported by specific documentation that proves both your medication exposure and the resulting health complications:

• Documented Medication Use: Prescription records from your pharmacy showing Ozempic, Wegovy, Rybelsus, Mounjaro, Zepbound, Trulicity, or Saxenda; medical records indicating dates prescribed and dosages taken; insurance statements reflecting filled prescriptions
• Diagnosed Qualifying Health Condition: For gastroparesis claims, results from properly performed gastric emptying studies (scintigraphy, breath test, or wireless motility capsule); for NAION vision loss, clinical examination by an ophthalmologist with specialized ocular imaging; for other conditions like ileus, severe vomiting, gallbladder removal, or pancreatitis, documented medical diagnosis and treatment records from qualified healthcare providers
• Causal Connection Between Medication and Injury: Medical timeline showing symptom onset during or shortly after semaglutide medication use; treatment records demonstrating ongoing medical care and specialist consultations; documentation of symptom severity and duration establishing the seriousness of your complications

Medical records should demonstrate that your gastrointestinal issues or other health complications developed during the period you were taking semaglutide medications or shortly after discontinuation, rather than years later when other factors might explain your condition.

Treatment records showing ongoing medical care, specialist consultations, and the severity of your symptoms help establish the seriousness and duration of your injuries.

If you or a loved one suffered severe gastrointestinal injuries, vision loss, or other debilitating complications after taking Ozempic, Wegovy, or similar GLP-1 medications, you may be eligible to seek compensation.

Receive an instant case evaluation from TruLaw today to learn if you qualify to join others in filing an Ozempic lawsuit.

Medical Documentation and Testing Requirements

Gastroparesis Testing Standards

Judge Marston’s August 2025 memorandum established strict evidentiary standards for gastroparesis plaintiffs in the MDL.

Rather than accepting clinical diagnosis based solely on symptoms and physical examination, the court requires objective proof through properly performed gastric emptying studies.

Three types of testing meet this standard:

1. Gastric emptying scintigraphy (the most common test using radiolabeled food);
2. Gastric emptying breath test (measuring carbon dioxide in breath samples); or
3. Wireless motility capsule (a pill-sized device that measures transit time through the digestive system).

This ruling affects many potential plaintiffs who received gastroparesis diagnoses based on their symptoms and clinical presentation without undergoing formal gastric emptying studies.

Patients who lack this documentation may need to undergo testing now to support their legal claims, though establishing current gastroparesis after discontinuing the medication presents challenges in proving causation.

Your legal team can guide you through obtaining proper testing and connecting historical symptoms to current diagnostic results.

Vision Loss and Other Injury Documentation

NAION vision loss claims require ophthalmologic examination documenting optic nerve damage, visual field testing showing characteristic vision loss patterns, and imaging studies ruling out other conditions that might cause similar symptoms.

Emergency room visits, hospital admission records, and documentation of ongoing specialist treatment demonstrate the severity and immediate impact of your life-altering complications.

The more detailed your medical documentation, the stronger your potential case.

Records should include dates of medication use, symptom onset timing, all diagnostic testing results, emergency department visits, hospitalizations, surgical interventions if required, and ongoing treatment plans.

This comprehensive documentation helps establish both that your injuries occurred and that they resulted from the medication rather than pre-existing conditions or other causes.

If you or a loved one suffered severe gastrointestinal injuries, vision loss, or other debilitating complications after taking Ozempic, Wegovy, or similar GLP-1 medications, you may be eligible to seek compensation.

Start your Ozempic claim evaluation with TruLaw to determine your eligibility and protect your legal rights.

Common Disqualifying Factors

Certain medical history factors may affect case qualification or complicate the ability to prove your injuries resulted from semaglutide medications.

Certain medical history factors may prevent case qualification or complicate proving your injuries resulted from semaglutide medications:

• Prior Gastric Surgery History: Previous gastric bypass, gastric banding, gastric sleeve procedures, or other stomach operations that alter digestive anatomy may preclude gastroparesis claims, as these surgeries can cause delayed gastric emptying independent of medication effects; however, other injuries like vision loss or ileus may still qualify
• Non-FDA-Approved Medications: Use of compounded or off-brand semaglutide obtained from weight loss spas, online pharmacies, or clinics selling non-FDA-approved formulations does not qualify, as the lawsuits target manufacturers of FDA-approved medications
• Chemotherapy Treatment: Active chemotherapy at the time symptoms developed may complicate cases, as cancer treatments themselves can cause gastroparesis and other gastrointestinal complications

If you’re unsure whether any of these factors affect your case, consulting with a legal team experienced in pharmaceutical litigation provides clarity.

Ozempic lawsuit attorneys at TruLaw partner with litigation leaders to evaluate your specific situation, review your complete medical history, and determine whether you qualify to pursue legal action despite potentially complicating factors.

Building a strong Ozempic lawsuit requires gathering thorough medical documentation that proves both your diagnosis and the connection between your injuries and semaglutide medication use.

The quality and completeness of your medical evidence directly impacts your ability to meet the court’s evidentiary standards and demonstrate the full extent of your damages.

Starting this documentation process early ensures you have the records needed to support your claim.

Prescription and Medication Use Records

Complete prescription records serve as the foundation of your claim by establishing exactly when you used Ozempic or other GLP-1 medications, what dosages you received, and how long your treatment continued.

Pharmacy records showing all filled prescriptions, including dates filled, quantities received, and prescribing physician information, should be obtained from every pharmacy you used.

Many pharmacies maintain electronic records going back several years, though you may need to request older records in writing.

Physician Records and Treatment History

Medical records from your prescribing physician document why the medication was prescribed (whether for diabetes management, weight loss, or other conditions) and any discussions about potential risks or warnings provided at the time.

Office visit notes from appointments where the medication was prescribed, ongoing management visits where dosage adjustments occurred, and any visits where you reported developing symptoms all become part of your case file.

Insurance statements and explanation of benefits documents provide additional verification of prescription fills and dates covered.

Multiple Medication Usage and Discontinuation

If you switched between different GLP-1 medications during your treatment (for example, starting with Ozempic and later moving to Wegovy or Mounjaro) documentation of all medications used helps establish your complete exposure history.

Records showing when and why you stopped taking the medication also matter, particularly if you discontinued due to developing severe side effects.

Diagnostic Testing and Treatment Records

Results from all diagnostic testing related to your complications form the core medical evidence in your case.

Gastroparesis and Gastrointestinal Testing

For gastroparesis claims, this means obtaining complete results from gastric emptying studies, including the testing facility’s report, images or raw data if available, and the interpreting physician’s analysis.

The test report should document delayed gastric emptying consistent with gastroparesis diagnosis and rule out other potential causes of your symptoms.

Endoscopy reports, if you underwent upper endoscopy or colonoscopy to investigate your symptoms, provide additional evidence of gastrointestinal complications.

These procedures may have revealed inflammation, blockages, or other physical findings related to your condition.

CT scans, MRIs, or other imaging studies ordered to evaluate abdominal pain, nausea, or vomiting should be included in your documentation.

Vision Loss Testing and Ophthalmology Records

For vision loss claims, obtain all ophthalmology records including initial examination notes documenting vision changes, visual field testing results showing areas of vision loss, optical coherence tomography (OCT) imaging of the optic nerve, and any other specialized testing performed.

Records from your optometrist or primary care physician noting vision complaints before referral to a specialist help establish the timeline of symptom development.

Emergency Treatment and Hospitalization Records

Emergency department records from visits related to severe vomiting, dehydration, abdominal pain, or acute vision changes demonstrate the severity and acute nature of your complications.

Hospital admission records, if you required inpatient treatment, show the seriousness of your condition and the level of medical intervention needed.

Surgical reports, if you underwent procedures to treat gallbladder disease, feeding tube placement, or interventions for intestinal blockage, document permanent effects of your injuries.

Ongoing Specialist Care Documentation

Ongoing treatment records from specialists in the medical community managing your condition (including gastroenterologists for digestive issues or ophthalmologists for vision problems) show that your complications continue to require medical care.

These records help establish both the permanence of your injuries and the ongoing financial and quality-of-life impacts you experience.

Financial Documentation of Medical Expenses and Lost Income

Building your claim requires comprehensive financial records that demonstrate the economic burden of Ozempic-related complications:

• Medical Bills and Healthcare Costs: Itemized bills from emergency department visits, hospital stays, physician consultations, specialist appointments, diagnostic testing facilities, surgical procedures, pharmacy costs for medications treating complications, and medical equipment like feeding tubes or nutrition supplements; insurance explanation of benefits statements showing both insurance payments and out-of-pocket costs including copays, deductibles, and coinsurance
• Out-of-Pocket Expenses: Receipts or credit card statements for costs not covered by insurance such as travel to medical appointments, home healthcare services, over-the-counter medications and nutritional supplements, and medical equipment or supplies needed for ongoing condition management
• Lost Wage Documentation: Pay stubs from before your injury showing regular earnings; employer letters documenting missed work time and leave of absence paperwork; documentation of any job changes or reductions in hours due to health complications; for self-employed individuals, tax returns, business records, and documentation of lost business opportunities
• Reduced Earning Capacity Evidence: Employer statements about job duties you can no longer perform; documentation of workplace accommodations required; vocational expert assessments of limitations affecting advancement opportunities; evidence of career changes necessitated by permanent health complications

For plaintiffs whose complications prevent returning to their previous work or require career changes, documentation from employers or vocational experts showing reduced earning capacity becomes important when seeking financial compensation.

This might include statements about job duties you can no longer perform, accommodations required, or limitations affecting advancement opportunities in your field.

Time limits for filing an Ozempic lawsuit vary by state and begin running from the date you discovered or should have discovered your injury, making prompt action important to preserve your legal rights.

These time restrictions, known as statutes of limitations, exist in every state and can bar your ability to seek compensation through this multidistrict litigation (distinct from a traditional class action lawsuit) if you miss the deadline.

The timing of when you file your claim within the MDL process also affects how your case proceeds and when you might see resolution.

State-Specific Statutes of Limitations

Most states impose statutes of limitations ranging from two to three years for personal injury and product liability claims related to pharmaceutical injuries.

However, these timeframes vary by jurisdiction, with some states allowing only one year to file while others provide up to six years.

The Discovery Rule and When the Clock Starts

Under Federal Rules of Civil Procedure, the clock typically begins ticking when you discover your injury or reasonably should have discovered it and learn that manufacturers failed to adequately warn consumers – not necessarily when you first took the medication.

For Ozempic cases, the discovery rule means your statute of limitations likely started when you received a diagnosis of gastroparesis, NAION, or another qualifying condition and learned of a potential connection to your medication use.

If you developed gastroparesis in early 2023 but didn’t learn until late 2024 that Ozempic might have caused it, your filing deadline probably began in 2024 when you made this connection.

However, some states apply stricter rules, and delay in seeking legal counsel after learning of the connection could jeopardize your claim.

Exceptions and Extensions to Filing Deadlines

Certain factors can extend statute of limitations deadlines in some jurisdictions.

If the manufacturer engaged in fraudulent concealment (actively hiding known risks from patients and physicians) some states allow additional time to file once the fraud is discovered.

Cases involving minors may have extended deadlines that don’t begin until the person reaches age 18.

Mental incapacity during the statute of limitations period can pause the clock in some states until capacity is restored.

MDL Participation and State Law Deadlines

The interaction between state statutes of limitations and federal MDL procedures adds another layer of timing considerations.

While your case joins the federal MDL for pretrial proceedings, state law still governs your filing deadline.

You cannot wait to see how the MDL progresses before deciding whether to file – you must file within your state’s limitations period to preserve your claim, even if you expect the MDL to take several years to resolve.

If you or a loved one experienced serious health complications after using Ozempic or similar GLP-1 medications, time limits may be running on your ability to seek compensation.

Don’t miss your filing deadline – get a free case evaluation from TruLaw immediately to protect your right to file an Ozempic claim.

MDL Timeline and Case Progression

The Ozempic MDL follows a structured timeline that affects when different aspects of your case move forward.

As of November 2025, the litigation is in the discovery and expert report phase.

This exchange of expert testimony on issues like medical causation, FDA warning standards, and pharmaceutical company conduct provides the scientific and regulatory foundation for the legal claims.

Bellwether Trial Selection and Expectations

Bellwether trial selection is expected to occur in mid-2026, with actual trials potentially beginning in late 2026 or early 2027.

These representative cases test the strength of legal theories, allow juries to evaluate evidence, and often lead to settlement negotiations once both sides see how juries respond to the facts.

However, bellwether trials represent only a small fraction of MDL cases – most plaintiffs will not see their individual cases tried during this phase.

Settlement Timeline and Resolution Expectations

The timeline from filing to potential Ozempic settlement varies, but most experts anticipate that no substantial settlements will occur before bellwether trial results provide both sides with information about case values.

This means cases filed in 2025 might not see resolution until 2027 or later, depending on how bellwether trials proceed and whether pharmaceutical manufacturers engage in serious settlement negotiations.

Despite these lengthy timeframes, prompt filing remains necessary.

Cases must be filed within applicable statutes of limitations to preserve eligibility for any eventual settlement or to maintain the option of proceeding to individual trial if the MDL does not produce satisfactory results.

Waiting to see MDL outcomes before filing could result in losing your right to compensation entirely if your statute of limitations expires.

The Importance of Filing Before Deadlines Expire

Once a statute of limitations expires, courts generally have no power to revive your claim regardless of the merits of your case or the severity of your injuries.

This harsh rule means that even if you have clear evidence that Ozempic caused devastating complications, missing your filing deadline by even one day typically results in case dismissal.

Courts enforce these deadlines strictly, with very few exceptions.

Common Misconceptions About Timing

Some plaintiffs mistakenly believe they should wait to file until their medical condition stabilizes or until they know the full extent of their injuries.

However, this approach risks missing filing deadlines entirely.

The better strategy involves filing your claim to preserve your rights while continuing to gather additional evidence and medical documentation.

Your case remains open and can be amended to include further evidence of additional damages or complications that develop later, but only if you filed before your statute of limitations expired.

Others worry that filing early in the MDL means waiting longer for resolution, thinking that cases filed later might resolve more quickly once settlement frameworks are established.

This reasoning fails to account for statutes of limitations – waiting could mean becoming ineligible for any settlement or resolution.

Additionally, cases filed earlier often have priority in bellwether selection processes, potentially leading to earlier resolution for some plaintiffs.

Protecting Your Legal Rights

TruLaw’s pharmaceutical litigation team helps clients file claims within appropriate deadlines while simultaneously gathering additional evidence and medical records to document patient safety concerns.

We partner with Ozempic litigation leaders who work to protect client rights throughout the process, ensuring that statute of limitations concerns don’t prevent you from seeking the compensation you deserve for injuries caused by inadequate warnings about GLP-1 medication risks.

Pursuing an Ozempic lawsuit involves multiple phases from initial consultation through potential resolution, with each stage playing a specific role in building your case and working toward compensation.

Pharmaceutical litigation against companies like Novo Nordisk and Eli Lilly follows structured procedures within the MDL framework designed to efficiently manage thousands of similar claims while preserving each plaintiff’s individual case.

The journey typically spans several years, but knowing what to expect helps you feel prepared at each stage.

Initial Case Evaluation and Attorney Consultation

The process begins with a free consultation where attorneys review your medical history, prescription details, symptom timeline, and existing documentation to assess whether your case meets eligibility criteria.

During this initial evaluation, legal teams verify that you used qualifying GLP-1 medications, developed recognized health complications within an appropriate timeframe, have proper medical testing to support your diagnosis, and fall within applicable statute of limitations for your state.

This consultation costs nothing and creates no obligation – attorneys offering free case evaluations in pharmaceutical litigation typically work on contingency fee arrangements where they receive payment only if they recover compensation for you.

This structure makes legal representation accessible to injured patients regardless of their financial circumstances, as you pay no upfront costs or hourly fees.

Forming the Attorney-Client Relationship

If your case qualifies, you’ll form an attorney-client relationship through a written agreement outlining the terms of representation, including the contingency fee percentage (typically 33-40% of any recovery) and who pays for case expenses.

Your attorneys will immediately begin obtaining your complete medical records through signed authorizations you provide.

This process involves requesting records from all treating physicians, hospitals, emergency departments, diagnostic testing facilities, pharmacies, and insurance companies.

Gathering thorough records early ensures your legal team has the documentation needed to file your claim and begin building your case.

Initial consultations also provide an opportunity to ask questions about the legal process, anticipated timelines, what level of involvement you’ll have in your case, and what outcomes might be realistic given the current state of the litigation.

Experienced pharmaceutical litigation attorneys can explain how the MDL process works and what role you’ll play as your case proceeds.

Filing the Claim and Joining the MDL

Once your case is ready to file, your attorneys prepare the formal legal pleading that will be submitted to federal court.

The Ozempic MDL uses a streamlined filing system involving a Master Complaint that outlines the legal theories and factual allegations common to all cases, along with Short Form Complaints for individual plaintiffs.

This system allows your attorneys to adopt the standardized allegations in the Master Complaint while preserving details specific to your individual injuries, medical history, and damages.

Naming Defendants and Legal Theories

Your lawsuit names the appropriate defendants based on which medications you took.

Novo Nordisk is named in cases involving Ozempic, Wegovy, or Rybelsus, while Eli Lilly is named for injuries related to Mounjaro or Zepbound.

The complaint states legal theories including:

• Failure to warn (claiming the manufacturer knew or should have known about serious risks but failed to provide adequate warnings);
• Inadequate testing (alleging insufficient safety studies before marketing);
• Design defect (arguing the medication is unreasonably dangerous);
• Breach of warranty (claiming the manufacturer made promises about safety that proved false); and
• Negligence in the manufacturing and marketing process.

Case Transfer and MDL Consolidation

Cases filed in various federal district courts across the country are transferred to the Eastern District of Pennsylvania for consolidated pretrial proceedings under Judge Marston’s supervision.

This transfer doesn’t mean giving up your individual case – your lawsuit maintains its separate identity and can be remanded back to your original jurisdiction for trial if it doesn’t settle during MDL proceedings.

The consolidation simply means that common discovery, expert development, motion practice, and other pretrial activities occur together to avoid duplicating efforts across thousands of similar cases.

After filing, your case enters the MDL system where it follows the case management orders and scheduling deadlines established by Judge Marston.

Your attorneys participate in coordinated discovery, submit to the authority of MDL leadership attorneys who make strategic decisions affecting all cases, and keep you informed about developments in the litigation.

Discovery, Expert Reports, and Potential Resolution

The discovery phase involves both sides exchanging evidence and information relevant to the claims and defenses.

Plaintiffs’ attorneys request internal company documents from Novo Nordisk and Eli Lilly regarding:

• Safety testing conducted before FDA approval;
• Adverse event reports received after medications reached the market;
• Communications about whether to add warnings to drug labels;
• Marketing materials and promotional campaigns; and
• Financial information about medication sales.

Defense attorneys request medical records, employment information, tax returns and financial documentation, and information about plaintiffs’ medical histories and pre-existing conditions.

Depositions and Witness Testimony

Depositions allow attorneys to question witnesses under oath, with testimony recorded for potential use at trial.

Defense attorneys may depose plaintiffs about their medical history, medication use, symptom development, and how their injuries have affected their lives.

Plaintiff attorneys depose company representatives about safety decisions, regulatory submissions, and internal knowledge about medication risks.

Expert witnesses from both sides may also be deposed about their opinions on medical causation, pharmaceutical regulation, and other technical issues.

Expert Witness Requirements

Expert witness testimony providing scientific evidence forms a foundational part of pharmaceutical litigation.

Plaintiffs must present experts who can provide significant evidence about medical causation (explaining how GLP-1 medications cause the injuries alleged), regulatory standards for adequate warnings, and the economic value of damages including future medical expenses and lost earning capacity.

Judge Marston ruled in August 2025 on which expert testimony meets federal standards for reliability and relevance, decisions that shape what evidence juries will be allowed to hear.

Bellwether Trials and Settlement Outlook

Bellwether trials represent the next major milestone, expected to begin in late 2026 or 2027.

A small number of representative cases proceed to trial first, allowing juries to evaluate evidence and reach verdicts that inform both sides about case values and liability issues.

Strong plaintiff verdicts often motivate pharmaceutical companies to engage in settlement negotiations, while defense verdicts might embolden companies to resist settlements and prepare for more trials.

Most MDLs eventually produce settlement frameworks after several bellwether results provide both sides with sufficient information to value cases accurately.

How TruLaw Supports Your Ozempic Claim

TruLaw partners with Ozempic litigation leaders and medical experts to build strong cases supported by thorough documentation and reliable expert testimony.

Our team handles all legal procedures and deadlines, participates in coordinated discovery and motion practice, and works to secure the best possible compensation for medical expenses, lost wages, pain and suffering, and future medical needs related to semaglutide injuries.

If you or a loved one developed gastroparesis, NAION vision loss, or other serious complications after taking Ozempic, Wegovy, or similar GLP-1 medications, you may be eligible to seek compensation.

Let TruLaw evaluate your case to determine your options and next steps in the Ozempic litigation process.

Damages plaintiffs may recover through Ozempic lawsuits address both financial losses and the personal impact these injuries have on daily life and future wellbeing.

While no global settlement has been announced as of November 2025, individual settlements and future trial verdicts will determine compensation based on:

• Injury severity;
• Medical expenses incurred and anticipated;
• Lost income and reduced earning capacity; and
• The profound ways these complications have diminished quality of life.

Each case is valued individually, with more severe and permanent injuries typically warranting higher compensation.

Economic Damages and Medical Expenses

Plaintiffs may recover compensation for quantifiable financial losses stemming directly from Ozempic complications:

• Past Medical Expenses: Emergency room visits for severe vomiting, dehydration, or acute symptoms; hospitalizations including room charges, physician fees, nursing care, medications, and facility costs; gastric emptying studies and other diagnostic testing; endoscopies, imaging studies, and specialized evaluations; consultations with gastroenterologists, ophthalmologists, and other specialists; prescription medications to manage symptoms; nutritional support products or feeding tube supplies
• Future Medical Care Costs: Ongoing gastroparesis management including dietary modifications, symptom-managing medications, regular gastroenterology monitoring, and potential surgical interventions; vision loss treatment including low-vision rehabilitation services, adaptive equipment and technology, ongoing ophthalmology care, and treatment for secondary complications; economic expert projections calculating the present value of lifelong medical needs
• Lost Wages and Income: Wages lost during acute illness, hospital stays, medical appointments, and recovery periods; documentation from employers confirming missed workdays; pay stubs showing regular earnings before and after injury; tax returns for self-employed plaintiffs demonstrating income disruption
• Diminished Earning Capacity: Permanent complications preventing return to previous employment or requiring career changes; vocational expert evaluations of education, work history, transferable skills, physical limitations, and labor market conditions; compensation for reduced lifetime earning potential when chronic conditions end careers or limit advancement opportunities

Economic damages provide concrete compensation for quantifiable financial losses, but they represent only part of the total harm experienced by plaintiffs whose lives have been dramatically altered by inadequate warnings about medication risks.

Non-Economic Damages and Quality of Life Impact

The personal toll of Ozempic complications extends beyond financial losses to affect every aspect of daily living:

• Pain and Suffering: Chronic nausea and vomiting multiple times daily; severe abdominal cramping and bloating; physical pain from gastric emptying studies, endoscopies, and surgical procedures; permanent vision loss and daily challenges of managing life without sight; ongoing symptoms persisting despite treatment; compensation based on duration, intensity, and whether conditions are temporary or permanent
• Emotional Distress and Mental Anguish: Anxiety and depression resulting from chronic health conditions; fear about future complications and declining health; psychological trauma from hospitalizations, surgeries, or permanent disability; frustration and grief over lost abilities and new limitations; financial strain stress; many plaintiffs require mental health treatment including therapy or psychiatric medication
• Loss of Enjoyment of Life: Inability to enjoy meals and social events centered around food due to gastroparesis; vision loss eliminating activities like reading, driving, watching movies, or visual hobbies; chronic illness limiting physical activities, travel, exercise, and recreational pursuits; interference with family activities, relationships with children, and community participation; younger plaintiffs facing decades of these limitations potentially receiving higher compensation
• Loss of Consortium Claims: Available to spouses when injuries affect marital relationships; compensation for loss of companionship, affection, and emotional support; diminished physical intimacy; reduced ability to participate in shared activities; burden of providing caregiving and assuming additional household responsibilities; separate damages belonging to the spouse rather than the injured plaintiff

TruLaw works to secure full compensation addressing both economic losses and the profound impact that Ozempic complications have on clients’ quality of life.

We partner with medical and economic experts to thoroughly document damages and present compelling cases for the best possible recovery, whether through negotiated settlement or trial verdict.

If you or a loved one suffered serious health complications after taking Ozempic, Wegovy, or similar GLP-1 medications, you may be eligible to seek compensation for medical expenses, lost income, pain and suffering, and reduced quality of life.

Pursue your compensation claim with TruLaw’s experienced pharmaceutical litigation team by filing an Ozempic lawsuit today.

Our Ozempic attorney at TruLaw is dedicated to supporting clients through the process of filing an Ozempic lawsuit.

With extensive experience in dangerous drug and pharmaceutical litigation cases, Jessica Paluch-Hoerman and our partner law firms work with litigation leaders and medical experts to prove how Ozempic (semaglutide) injections caused you harm.

TruLaw focuses on securing compensation for medical expenses, hospitalization costs, lost wages, pain and suffering, and other damages resulting from your Ozempic-related injuries including gastroparesis, intestinal blockages, gallbladder issues, and other severe gastrointestinal complications.

We understand the physical and emotional toll that Ozempic complications have on your life and provide the personalized guidance you need when seeking justice.

Meet the Lead Ozempic Attorney at TruLaw

Meet our lead Ozempic attorney:

• Jessica Paluch-Hoerman: As founder and managing attorney of TruLaw, Jessica brings her experience in pharmaceutical litigation and personal injury to her client-centered approach by prioritizing open communication and personalized attention with her clients. Through TruLaw and partner law firms, Jessica has helped collect over $3 billion on behalf of injured individuals across all 50 states through verdicts and negotiated settlements.

How much does hiring an Ozempic lawyer from TruLaw cost?

At TruLaw, we believe financial concerns should never stand in the way of justice.

That’s why we operate on a contingency fee basis – with this approach, you only pay legal fees after you’ve been awarded compensation for your injuries.

If you or a loved one experienced severe gastrointestinal complications, gastroparesis, intestinal blockages, gallbladder problems, or other serious health issues after using Ozempic for diabetes management or weight loss, you may be eligible to seek compensation.

Contact TruLaw using the chat on this page to receive an instant case evaluation and determine whether you qualify to join others in filing an Ozempic lawsuit today.

Ozempic lawsuits allege inadequate warnings and are being filed by individuals across the country who suffered severe gastrointestinal complications and other serious health problems after using the diabetes and weight-loss medication.

TruLaw is currently accepting clients for the Ozempic lawsuit.

A few reasons to choose TruLaw for your Ozempic lawsuit include:

• If We Don’t Win, You Don’t Pay: The Ozempic lawyers at TruLaw and our partner firms operate on a contingency fee basis, meaning we only get paid if you win.
• Expertise: We have decades of experience handling dangerous drugs cases similar to the Ozempic lawsuit.
• Successful Track Record: TruLaw and our partner law firms have helped our clients recover billions of dollars in compensation through verdicts and negotiated settlements.

If you or a loved one developed gastroparesis, intestinal blockages, gallbladder problems, persistent vomiting, or other severe gastrointestinal complications after using Ozempic for diabetes management or weight loss, you may be eligible to seek compensation.

Contact TruLaw using the chat on this page to receive an instant case evaluation that can determine if you qualify to join others in filing an Ozempic lawsuit today.